síndrome doloroso regional complejo tipo 1: un diagnóstico elusivo complex regional pain syndrome type 1: an elusive diagnosis

Clicks: 256
ID: 146187
2009
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #30 of 101 articles by views in proceedings on: 2016 ieee central america and panama student conference, conescapan 2016

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
El síndrome doloroso regional complejo tipo 1 es una afección que puede complicar traumatismos, en especial de los miembros. Es infradiagnosticado y potencialmente muy incapacitante. El diagnóstico se realiza reuniendo una serie de criterios clínicos. No existe un método de diagnóstico complementario que pueda considerarse patrón de oro. Su tratamiento debe ser multidisciplinario (fármacos, terapia física, terapia psicológica y en casos seleccionados, procedimientos invasivos). Se han comunicado resultados favorables con múltiples tratamientos farmacológicos, siendo la terapia con corticosteroides una de las que han alcanzado altos niveles de evidencia a favor de su utilidad. Presentamos el caso de un paciente masculino de 47 años de edad que fue internado en nuestro servicio por dolor intenso en su extremidad inferior derecha de características neuropáticas de larga evolución. Había realizado múltiples consultas previas y cumplido diversos tratamientos. Se le realizó centellograma óseo de tres fases con 99Tc que resultó compatible con el diagnóstico propuesto. Se trató con metilprednisona 60 mg/día con disminución progresiva hasta completar 15 días, obteniéndose una mejoría significativa de la sintomatología. Se le otorgó el alta hospitalaria para proseguir la rehabilitación ambulatoria.
Complex regional pain syndrome type 1 is a painful disorder that may complicate a traumatic lesion especially in extremities. It is infradiagnosed and potentially very disabling. Its diagnosis consists of a few clinical criteria. It does not exist a complementary diagnostic study which can be considered as gold standard. Its treatment must be multidisciplinary (e.g. medicines, physical therapy, psychological therapy and, in selected cases, invasive procedures). There have been communicated some favorable results using multiple pharmacological treatments in which corticosteroid therapy was among the ones that have reached highest levels of evidence in favor of its utility. Here we present the case of a forty-seven male patient who presented severe pain in his right lower extremity with neuropathic characteristics and a long time of evolution. He had had multiple previous consultations and he had carried out many other treatments. It has been performed a 99Tc three- phase bone scintigraphy that was compatible with the proposed diagnosis. He was treated with methyl prednisone 60 mg q24h with progressive lowering doses during fifteen days with a significant improvement of signs and symptoms. Finally he received hospital discharge for ambulatory rehabilitation treatment.
Reference Key
jones2009medicinasndrome Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Roberto M. Forden Jones;Rubén J. De Marco;Flavio A. Dombrowski;Ariel F. Sáez De Guinoa
Journal proceedings on: 2016 ieee central america and panama student conference, conescapan 2016
Year 2009
DOI
DOI not found
URL
http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802009000600012
Keywords
allergyinfectious and parasitic diseases

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.